NRAS and central nervous system cancer: However, it is clear that BRAF WT cells also respond to iHsp90s with increased antigen expression, as cells expressing only NRAS mutations, as well as cells that are WT for both of these genes, (such as the human gliomas [46]) and the murine melanoma) all are susceptible to iHsp90 antigen induction.